PET-CT在霍奇金淋巴瘤中的应用：第54届美国血液学会年会报道

Application of PET-CT in Hodgkin＇s lymphoma： a report from the 54th ASH annual meeting

近年来,在对霍奇金淋巴瘤（HL）的研究中,PET-CT发挥着越来越重要的作用,被认为是HL分期、疗效监测与评估的最准确工具.它具有较高的敏感性和特异性,可以监测治疗期间的疗效,准确区分受累淋巴结和组织,评估预后,已成为淋巴瘤治疗不可缺少的一部分.但是作为一种较新的影像技术,PET-CT的全部作用或优缺点还没有被完全研究清楚.文章从2012年第54届美国血液学会（ASH）年会临床试验的最新结果和PET-CT在临床上的应用经验,来探讨其优缺点.

In recent years,PET-CT plays an important role in Hodgkin＇ s lymphoma （HL）.It has emerged as the most accurate tool for staging,treatment monitoring,and response evaluation in HL.PET-CT has high sensitivity and specificity.It provides an opportunity to monitor the quality of response during treatment,permits separation of node from involved regions,and adds prognostic information.PET-CT has become integral to modern lymphoma management,but as a relatively new imaging technique it is still being studied and neither its full potential nor major limitations have been fully understood.The recent observations from clinical trials and clinical experiences with PET-CT in the 54th ASH annual meeting are discussed to explore its advantages and limitations.